chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This child was given shots 05/06/09.  On 5/11/09 the mother noticed a rash on her face which she best describes as looking like heat rash.  On 5/13/09 the rash spread down her arms and onto her feet small blisters noted. Then she took the child to a local ER where they diagnosed the illness as hand foot and mouth disease or chickenpox.  On 05/18/09 the child did not appear to be getting better so the mother took her to her regular MD who diagnosed poison ivy.  On 05/23/09 the rash still did not seem to be getting better with prescribed prednisone cream so the mother returned to the local ER.  This time they ran blood tests which concluded high liver enzymes and elevated platelet count. The local ER referred her to a dermatologist.  On 05/23/09 the child was seen by a dermatologist who diagnoised the illness as Gianotti Crosti Syndrome, a rare illness, associated with rash and elevated liver enzymes.  Some information available on the internet associated the MMR vaccine with the illness.
This is a spontaneous report received from a contactable consumer(patient). A 62-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE - solution for injection; lot number and expiry date were not reported) via an unspecified route of administration, at the left  arm, on 21Aug2021 11:00, at dose 1, single for covid-19 immunisation in a pharmacy or drug store. Relevant medical history included blood pressure increased. Concomitant medications in two weeks include gabapentin and unspecified BP medicine. The patient previously took codeine and experienced allergy. The patient did not have other vaccine in four weeks. The patient did not have prior COVID vaccination and was not tested post vaccination. In Aug2021 at 03:00, also reported as 01Aug2021, the patient experienced Diarrhea - loose & watery. Therapeutic measure taken in response to the event included administration of imodium. The outcome of the events was not recovered.
runny nose; fever; chills; This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration date: not reported), via an unspecified route of administration on 04Mar2021 as single dose for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included paracetamol (TYLENOL). The patient got her 1st dose of the vaccine on 04Mar2021 and she took TYLENOL before she got the vaccine and wanted to know if that was okay. On 05Mar2021 (last night), the patient also had a fever, chills, and runny nose. The outcome for all events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Aortic stenosis/aorta stenosis; pulmonary stenosis; extreme pain in my whole body; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: AORTIC STENOSIS (disability, medically significant), outcome "unknown", described as "Aortic stenosis/aorta stenosis"; PULMONARY VALVE STENOSIS (disability, medically significant), outcome "unknown", described as "pulmonary stenosis"; PAIN (disability, medically significant), outcome "unknown", described as "extreme pain in my whole body". Clinical Course: Patient was perfectly healthy until patient took ER Covid vaccine. Patient's health went to hell and now on disability. WHY? Patient felt like human test rat. Patient had to go on disability and could not pay for daughters wedding on top of had to give car back and also almost lost house!  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Patient is a 78-year-old female who presented to the emergency department on 11/18/21 with complaint of fever, diffuse myalgias and malaise.  She is a poor historian.  States onset of symptoms was yesterday at some point.  States he had some nasal congestion and felt some chills and generally felt poorly.  She is fully vaccinated for COVID with the Moderna vaccine completed about 6 months ago.  Is uncertain where she would have exposed.  In the emergency department she was noted to have fever of just under 103°.  She has been doing some extra work of breathing with borderline hypoxia.  She denies that she has been wheezing.  States she has been coughing but no purulent sputum.  No nausea or vomiting.  Blood pressure has been stable.  Secondary to the borderline respiratory status and her fever she is being admitted to the hospital.Chest x-ray was positive for right lower lung atelectasis and also  had COVID test that was positive.  Cardiac BNP, troponin, blood cultures are  all negative.  The patient was admitted in the hospital and also tried IV ,  then ceftriaxone and azithromycin, and patient tolerated fairly well, and  also had infection markers.  Ferritin was 124 and cardiac BNP was negative.   Lactic acid was only 1.37.  Troponin was negative.  White blood count and  hemoglobin were normal.  Liver function tests were normal and patient was able  to walk fairly well in the room with no hypoxia and down to 89 for a few  seconds and then came back up, and she is comfortable going home.  Patient was  advised to be discharged on p.o. dexamethasone for a few more days and p.o.  Levaquin every other day for 5 more doses, and follow up as an outpatient. Discharged on 11/20/21
PATIENT WAS GIVEN A DOUBLE DOSE OF VARICELLA DUE TO RECEIVING PROQUAD AND VARIVAX. NO AFTER EFFECTS FROM DOUBLE DOSE.
seizures; tired; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age (reported as Age: 65, Unit: Unknown) and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided) via an unspecified route of administration on 30Mar2021 as a single dose for COVID-19 immunisation. Medical history included cancer. Concomitant medication included unspecified pills. The patient called in to find out how they could reschedule their appointment for their second dose of Pfizer-BioNTech COVID-19 vaccine. During the call, the patient stated "I have seizures, I got a shot but I was supposed to get another today but I couldn't make it cause I have seizures. I have seizures so you have to be careful with me. You know when they shot you in your arm so you won't get sick. It's people in my building that was sick, sick from that stuff." When asked by the call agent if the patient was calling with regards to Pfizer-BioNTech COVID-19 vaccine. The patient stated "Yes, exactly I got the first shot on the 30th of March I got that shot that day, but I was supposed to come today, I should have been up there this morning but I didn't make it." The agent asked if the patient felt their seizure was brought on by the vaccine. The patient stated "No, I don't know, to be honest with you, I feel better I mean really feel better but I was scared because I know I should have got another shot. It's not because of where they shot me, it's just what I didn't do. I didn't take my pills. I got ran over my head so I have seizures if I don't take those pills then I'll have a seizure. It was not cause by the shot and it has nothing to do with where I'm at. It messed with me cause I hadn't taken my pills and that's what the problem was. I'm skinny anyway I will be for the rest of my life cause I had cancer. I'm sorry I'm just tired". The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: The event "seizures" was most likely an underlying condition, unrelated to suspect vaccine BNT162B2.
Patient came to pharmacy to report numbness and weakness of (R) hand. Symptoms started 2 day after vaccination. Husband stated symptoms were improving. Patient was told to see primary care provider and has appointment scheduled 11/30/15. Patient told to see provider sooner if symptoms do not continue to improve. I called pt.
Mom states child very ill that first night with higher temperature, crying, very irritable. Left leg at immunization site very red, warm to touch. Next AM mom called Dr, advised clinic visit. Dr gave antibiotics/warm soaks for leg but told mom "the shot was given in fat not muscle." 3 days later child seen in clinic here without any symptoms.
Information has been received from a physician concerning a 12 month old female who on an unspecified date was vaccinated with a dose of ProQuad. Concomitant vaccination included influenza virus vaccine (unspecified) (manufacturer unknown). Subsequently, on the same day, the patient experienced a "local reaction at the injection site while she was in the office". Medical attention was sought and the patient received diphenhydramine hydrochloride (Benadryl). The patient's status was not reported. No further information was available. There was no product quality complaint involved. The patient receiving diphenhydramine hydrochloride (Benadryl) for an injection site reaction was considered to be an other important medical event (OMIC). Additional information has been requested.
This spontaneous report as received from a nurse refers to a 77 year old patient of unknown gender. No medical history provided. On 14-MAY-2013 the patient was vaccinated with ZOSTAVAX (dosing, frequency, indication; lot # J000492, exp 19-JAN-2014). The vaccine had been improperly stored at minus 5C since 16-APR-2013. Unknown whether the patient had been using any concomitant medications. No adverse event was reported. Additional information has been requested.
Extreme dizziness.  Felt a bit clouded in the first 24 hours after the second shot of Moderna's Covid vaccine.  The morning of the second day I woke up extremely dizzy. Hard to get up.  Still experiencing dizziness. By dizziness I mean  "Disequilibrium relates to a feeling of unsteadiness or impending fall. " Again, this is after the second shot Lot information above is for second shot Lot # for first shot was 012A21A
Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, MD Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date 12/11/2022  PRESENTING PROBLEM: Flash pulmonary edema (HCC) [J81.0] Hypoxia [R09.02] Acute on chronic congestive heart failure, unspecified heart failure type (HCC) [I50.9]   HOSPITAL COURSE: Patient is a 88 y.o. female with past medical history of chronic diastolic CHF, Crohn's disease, CKD stage IIIA, permanent atrial fibrillation on Xarelto, hyperthyroidism and pulmonary hypertension who presented with shortness of breath. She was brought in by EMS and in the ER was found to have COVID-19, CXR with pulmonary edema, and started on HFNC and Lasix. She was admitted to medicine for further evaluation.    Oxygen was able to wean down to nasal cannula. Continued on steroids while on oxygen. Continued Lasix to diurese. She underwent TTE to further evaluate which showed a newly decreased EF to 43% with minor RWMA. Cardiology was consulted. She underwent a Lexiscan which showed no myocardial ischemia, and return of EF to normal. Lasix was switch to oral dosing.   On initial CXR in ER there was note of a thyroid mass with unclear nature. A CT thorax was completed to further evaluate this and showed a goiter that is causing mass effect on the trachea. This is a chronic problem the patient is well aware of. She follows closely with Dr. (Endocrinology) to monitor this and wants to avoid further interventions if possible. She was in stable condition and discharged home on 12/16/2022.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age who 2 weeks ago (on 25-OCT-2012 approximately) was vaccinated with ZOSTAVAX (dose, lot and route not reported). No other co-suspects were reported. No concomitant medications were reported. It was reported that the patient would be have an elective surgery for other issue unrelated to with ZOSTAVAX. Upon internal review Elective surgery was considered to be medically significant. Additional information is not expected.
Information has been received from a physician who reported that a parent of one of her patient's told her that on 21-JUL-2008 that she heard a news story on a television station geared toward Hispanics, that "about 90" girls were paralyzed on GARDASIL. Upon internal review, paralysis was considered an other important medical event. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Additional information has been requested.
Pt recvd vax & did not seroconvert; 11 of 16 dialysis pts were vaxed w/Hep B vax & were anti-HBs neg approx 3 months p/series; on f/u lab testing in JUL92 showed HBs antibody 146.9; pt devel ruptured abdo aneurysm & died on 2JUL93;
adult patient received a pediatric dose; adult patient received a pediatric dose; second dose longer than 1 month; This case was reported by a pharmacist and described the occurrence of underdose in a 27-year-old male patient who received HBV (Engerix B pediatric) (batch number LM992, expiry date 13th December 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included HEPATITIS B VACCINE (ENGERIX B).   On 6th October 2021, the patient received the 2nd dose of Engerix B pediatric .5 ml and Engerix B Pre-Filled Syringe Device. On 6th October 2021, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose, adult use of a child product and drug dose administration interval too long. On an unknown date, the outcome of the underdose, adult use of a child product and drug dose administration interval too long were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that the patient received 1st dose of Engerix B on 29th July 2021. The patient received a pediatric dose (half dose) of Engerix B later than the recommended interval, which led to underdose, adult use of a child product and drug dose administration interval too long. The reporter stated that it had been longer than 1 months since patient got first dose of Engerix B. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
arm stiffness, cough, dizziness, ringing in ears, muscle aches and spasms.  Seeing Primary care for symptoms and dizziness has not improve and ringing in ears has worsen.  Recommend from to get a MRI.
Patient states she had high fever 101.7 and nausea. She contacted er staff and was told to rest, if symptoms got worse to come in. Patient states feeling better but wanted to report reaction and to see if common.
They started on Saturday. I woke up with a fever 99.8, headache, sore throat. On Sunday I started with body aches. I called my doctor Monday morning first thing. I took a test on Saturday and then another on Monday. He prescribed PAXLOVID the five-day dosage. I started on that, and my symptoms went away within the first few days. The following Saturday 3/24/2023 I took a test and I was negative.
Golf ball sized swelling and redness that increased to softball size per mom. In office on 08/16/2013 area measures 3in x 3.5in.
Patient reported burry vision, which started the evening after receiving her shot.  She also reported light sensitivity and the symptoms lasted about 2 and half days.
Mild fever Sore arms  Body aches Headaches Congestion  Exhausted
(Left Lat Thigh) redness, swelling, hard area on July 17, 2015. Hib vaccine given on 7-16-2015 states mom here at HC. Mom came to clinic 7-21-2015 with son/grandma. Dr did look at site. Our clinic was closed 7-17-2015. Swelling decreased on Monday, redness noted close at site with hard lump.
Given vaccine on 9-21-12. Came to office on 10/1/12 with red, raised, bumpy rash on (R) leg. Fever 101.7.
pain on my arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain on my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain on my arm). At the time of the report, VACCINATION SITE PAIN (pain on my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications and treatment information was not provided by the reporter.
WOKE UP WITH A BURNING AT THE LOCATION OF MY LIVER IT THEN RADIATED OUT TO ALL SECTIONS OF MY TORSO LASTED FOR A FEW MINUTES AN THEN SUBSIDED. IT THEN SEEMED TO SETTLE IN MY SHOULDERS AS A TINGLE ACHY FELLING AND LASTED FOR ABOUT 8 HOURS  IT WOULD COME IN WAVES AND VARY IN INTENSITY.
Pt was out running at clinic this AM when he had a syncopal episode, EMS reported pt had a 104.1; tympanic temp on scene, RLE sharp pain and noted LOC for 30 seconds.  Team members were able to facilitate pt to the ground w/o any other injuries.
Throat feels very closed and tight. Sometimes cough accompanies the pain. Severe headache. Pain when swallowing. Began taking cold/flu medicine with no help.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 16-JUL-2014, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
This spontaneous report was received from a registered nurse and refers to a 13-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 19-DEC-2018, the patient was vaccinated with improperly stored dose of VAQTA, lot # R018935, expiration date 05-SEP-2019 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/ 0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (It was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient). Sender's Comments: US-009507513-1901USA000071.
My left ear is mostly deaf. I feel a bit of pressure in the affected ear. No tinnitus.
This spontaneous report as received from a Doctor of Pharmacy refers to a patient of unknown age. The patient was vaccinated with lot # (1013Z expiration 30-JUL-2012) of M-M-R II (dose and route not reported) on 03-AUG-2012. No adverse effect were reported. Additional information has been requested.
Patient called in on 7/16 to report a reaction to the Pneumovax. He says he has a 2"x5" red, raised patch in the area of the vaccination. He said it is swollen, but not painful except painful to the touch. It started the morning after vaccine administration, but has not worsened throughout the day.
This spontaneous report was received from a registered nurse referring to a 6 month old female patient. The patient had no relevant medical history, drug reactions/allergies or concomitant medications. The reporter informed that the patient had completed a hepatitis B series with hepatitis b vaccine (recombinant) (manufacturer unknown) for prophylaxis (strength, route, dosage schedule and lot number were not reported) which was administered on 02-JUN-2004, 30-NOV-2004 and 08-MAR-2005. On an unspecified date (reported as "before August 2017"), the patient's had hepatitis B titers drawn and were not where the doctor wanted them to be. The patient did not seek medical attention, but she received treatment for the adverse event. No studies or diagnostic tests were carried out. Then on 18-AUG-2017, the patient was vaccinated with RECOMBIVAX HB lot number: N006321 (expiration date: 08-NOV-2019) and on 20-OCT-2017, the patient received another dose of RECOMBIVAX HB lot number: N002920 (expiration date: 30-SEP-2018). The outcome of hepatitis b surface antibody negative was unknown. The reporter did not assess the relatedness of RECOMBIVAX HB with hepatitis b surface antibody negative.
1/21/22: Diarrhea for the past 10 days.  Patient does report some associated upper abdominal pain that he describes as tightness.  He reports he has also had nausea and vomiting for the past 2 days.  Patient states he has also experienced some dizziness when standing.  He reports back pain, more predominantly at night.
About 6-7 days after vaccine administration noticed arm was erythematous and itchy over area where vaccine was administered. Also noted slight bump under the skin in same area.
Patient states arm rt deltoid became increasingly painful and swollen.  Unable to sleep on that are due to pain. She stated that she has a "fickle" immune system that has required treatment before for other reactions.  She may have a yeast allergy.  She was referred to her doctor because of the immune system concerns.